Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

(2015) N. A. Rizvi et al.   SCIENCE

On the explaining-away phenomenon in multivariate latent variable models

(2014) Peter van Rijn et al.   BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

(2014) Sylvia Adams et al.   JOURNAL OF CLINICAL ONCOLOGY

Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma

(2014) Sara Harcharik et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

(2014) Alexandra Snyder et al.   NEW ENGLAND JOURNAL OF MEDICINE

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma

(2014) Rosalyn Jewell et al.   Pigment Cell & Melanoma Research

Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma

(2013) G. Safaee Ardekani et al.   BRITISH JOURNAL OF DERMATOLOGY

The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures

(2013) Jérôme Galon et al.   IMMUNITY

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

(2013) Sherene Loi et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

(2013) Dale Han et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis

(2013) Meng Qian et al.   MELANOMA RESEARCH

Dendritic Cell-Targeted Approaches to Modulate Immune Dysfunction in the Tumor Microenvironment

(2013) Anne Gallois et al.   Frontiers in Immunology

Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain

(2012) José Antonio Avilés-Izquierdo et al.   Clinical & Translational Oncology

Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?

(2012) Alexander M.M. Eggermont et al.   CURRENT OPINION IN ONCOLOGY

Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma

(2012) Alexander M.M. Eggermont et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma

(2012) Farhad Azimi et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

(2011) David Capper et al.   ACTA NEUROPATHOLOGICA

Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991

(2011) Alexander M.M. Eggermont et al.   EUROPEAN JOURNAL OF CANCER

Tumor progression by immune evasion in melanoma

(2010) Mohammed Kashani-Sabet   CANCER

The biology behind prognostic factors of cutaneous melanoma

(2010) Alan Spatz et al.   CURRENT OPINION IN ONCOLOGY

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database

(2009) M. Mandalà et al.   EUROPEAN JOURNAL OF CANCER

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

(2009) D. Bogunovic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The reactive oxygen-driven tumor: relevance to melanoma

(2008) Levi Fried et al.   Pigment Cell & Melanoma Research

Phase- and Stage-Related Proportions of T Cells Bearing the Transcription Factor FOXP3 Infiltrate Primary Melanoma

(2007) Giuseppe De Panfilis et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY